Wednesday Jun 28, 2023

July 2023: Whither evidence, COI in guidelines, isotretinoin safety, SGLT2 inhibitors and Utrogestan shortage

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the July 2023 issue of DTB. They discuss evidence-based medicine, access to evidence and increasing use of press releases and social media to present evidence ( They talk about the safety of isotretinoin ( and review a study that assessed the accuracy of conflict of interest statements in clinical guidelines ( The main review article explores the evidence for cardiac and renal effects of SGLT2 inhibitors ( They begin by discussing the impact of the shortage of Utrogestan.

Copyright 2023 All rights reserved.

Version: 20240320